Innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models are some of the factors driving the growth of the mice model market. The mice model market is expanding with the increase in R&D activities in pharmaceutical industries. These mice model are being used in many applications such as oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies.

Growing consumption of personalized medicine designed through the use of mice model, drives the global mice model market.

Personalized medicine is the process of developing tailored medications to target individualized treatment and care based on personal and genetic variation. These medicines are designed through the use of animal models, particularly mice models. In this process, immune-deficient models are transplanted with human tissues and the disease expressed is recorded. This is followed by treating the model with a whole series of drugs or gene therapies to find the most suitable treatment, thus generating suitable or personalized medicines for patients.

On the basis of technology, the mice model market is segmented into CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-mediated gene transfer, virus/vector-mediated gene transfer, liposome-mediated DNA transfer, electroporation of DNA, biolistics, and TALENs & ZFNs). The CRISPR segment accounted for the largest share of the mice model market in 2016. The large share of this segment is mainly attributed to the fact that CRISPR is the most widely used technique due to the various advantages associated with it, such as ease of design, high efficiency, and relatively low cost.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308

On the basis of therapeutic area, the mice model market is segmented into oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies, and other disease studies (mice models for rare diseases and metabolism & regulatory disorder studies, hematopoiesis, renal and toxicology studies). The oncology studies segment commanded the largest share of the mice model market in 2016. The large share of this segment can primarily be attributed to the growing cancer research activities and increasing innovation in mice models that are tailored to meet cancer research needs.

Mice model applications in various therapeutic indications such as immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, diabetes studies, and other disease studies (mice models for rare diseases and metabolism & regulatory disorder studies, hematopoiesis, renal and toxicology studies) coupled with the ongoing innovations in mice models drive the growth of mice model market.

Growing use of rat models, regulations & laws formulated for ethical use of animals and increased benefits offered by cryopreservation are the major factor restraining the growth of the market.  Various regulations and laws have been laid down by governments for ensuring ethical use of animals in research activities. Research institutes and companies carrying out studies on animals have to comply with these standards and requirements formulated for animal testing.

Key Players

The key players in the global mice model market include Charles River Laboratories International (US), The Jackson Laboratory (US), Taconic Biosciences (US), Envigo (UK), Laboratoratory Corporation of America Holdings (US), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC (Japan), genOway (France), and Horizon Discovery Group (US).

Inquiry about mice model market @
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1308